[go: up one dir, main page]

DE60015819D1 - Pyrazolopyridinon als Zwischenprodukt - Google Patents

Pyrazolopyridinon als Zwischenprodukt

Info

Publication number
DE60015819D1
DE60015819D1 DE60015819T DE60015819T DE60015819D1 DE 60015819 D1 DE60015819 D1 DE 60015819D1 DE 60015819 T DE60015819 T DE 60015819T DE 60015819 T DE60015819 T DE 60015819T DE 60015819 D1 DE60015819 D1 DE 60015819D1
Authority
DE
Germany
Prior art keywords
pyrazolopyridinone
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE60015819T
Other languages
English (en)
Other versions
DE60015819T2 (de
Inventor
Frank John Urban
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Products Inc
Original Assignee
Pfizer Products Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Products Inc filed Critical Pfizer Products Inc
Application granted granted Critical
Publication of DE60015819D1 publication Critical patent/DE60015819D1/de
Publication of DE60015819T2 publication Critical patent/DE60015819T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
    • C07D471/14—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Pulmonology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Immunology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Hydrogenated Pyridines (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)
DE60015819T 1999-04-30 2000-04-07 Pyrazolopyridinon als Zwischenprodukt Expired - Fee Related DE60015819T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US13194999P 1999-04-30 1999-04-30
US131949P 1999-04-30

Publications (2)

Publication Number Publication Date
DE60015819D1 true DE60015819D1 (de) 2004-12-16
DE60015819T2 DE60015819T2 (de) 2005-12-08

Family

ID=22451736

Family Applications (2)

Application Number Title Priority Date Filing Date
DE60006026T Expired - Fee Related DE60006026T2 (de) 1999-04-30 2000-04-07 Verfahren zur Herstellung von 8-cyclopentyl-6-ethyl-3 (substituierten)-5,8-dihydro-4H-1,2,3A,7,8-penta aza-as-Indacenen und dafür geeigneter Zwischenprodukte
DE60015819T Expired - Fee Related DE60015819T2 (de) 1999-04-30 2000-04-07 Pyrazolopyridinon als Zwischenprodukt

Family Applications Before (1)

Application Number Title Priority Date Filing Date
DE60006026T Expired - Fee Related DE60006026T2 (de) 1999-04-30 2000-04-07 Verfahren zur Herstellung von 8-cyclopentyl-6-ethyl-3 (substituierten)-5,8-dihydro-4H-1,2,3A,7,8-penta aza-as-Indacenen und dafür geeigneter Zwischenprodukte

Country Status (24)

Country Link
US (1) US6326495B2 (de)
EP (1) EP1048667B1 (de)
JP (1) JP3510560B2 (de)
KR (1) KR100346619B1 (de)
CN (2) CN1160353C (de)
AR (1) AR029450A1 (de)
AT (2) ATE282039T1 (de)
AU (1) AU761391B2 (de)
BR (1) BR0002070A (de)
CA (1) CA2307080C (de)
DE (2) DE60006026T2 (de)
DK (2) DK1048667T3 (de)
ES (2) ES2232805T3 (de)
HU (1) HUP0001700A3 (de)
ID (1) ID25705A (de)
IL (1) IL135809A0 (de)
IN (1) IN192746B (de)
MX (1) MXPA00004214A (de)
PL (1) PL339985A1 (de)
PT (2) PT1380585E (de)
RU (1) RU2189985C2 (de)
TR (1) TR200001161A2 (de)
TW (1) TWI256392B (de)
ZA (1) ZA200002057B (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MY148239A (en) 2009-08-13 2013-03-29 China Petroleum & Chemical A catalyst component for olefin polymerization and a catalyst comprising the same
BR112013005689A2 (pt) 2010-09-08 2016-05-03 Sumitomo Chemical Co método para produção de compostos de piridazinona e intermediário dos mesmos

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SU1094303A1 (ru) * 1982-12-24 1987-12-30 Институт физико-органической химии и углехимии АН УССР 3-Трифторметил-7-метилимидазо- @ 4,5-с @ -1,2,4-триазоло @ 4,3-а @ пиридин,обладающий спазмолитическим действием
US4940715A (en) * 1988-05-17 1990-07-10 Kissei Pharmaceutical Co., Ltd. 5H-pyrazolo[4,3-A] quinolizin-5-one compounds exhibiting therapeutic activities
NZ266525A (en) 1993-07-06 1997-10-24 Pfizer 4,5,6,7-tetrahydro-1h-pyrazolo[3,4-c]pyridine derivatives and medicaments
KR970707124A (ko) 1994-10-20 1997-12-01 스피겔 알렌 제이 비사이클릭 테트라하이드로 피라졸로피리딘 및 약제로서 이의 용도(bicyclic tetrahydro pyrazolopyridines and their use as medicaments)
JP3107827B2 (ja) 1995-06-06 2000-11-13 ファイザー・インコーポレーテッド トリサイクリック５，６−ジヒドロ−９Ｈ−ピラゾロ［３，４−ｃ］−１，２，４−トリアゾロ［４，３−ａ］ピリジン類

Also Published As

Publication number Publication date
KR20010029673A (ko) 2001-04-06
DE60015819T2 (de) 2005-12-08
EP1048667A1 (de) 2000-11-02
HK1031881A1 (en) 2001-06-29
ATE252582T1 (de) 2003-11-15
HUP0001700A3 (en) 2001-05-28
CN1249064C (zh) 2006-04-05
ID25705A (id) 2000-11-02
ATE282039T1 (de) 2004-11-15
TWI256392B (en) 2006-06-11
TR200001161A2 (tr) 2000-12-21
RU2189985C2 (ru) 2002-09-27
CN1478779A (zh) 2004-03-03
DE60006026T2 (de) 2004-06-17
AU3018000A (en) 2000-11-02
MXPA00004214A (es) 2002-03-08
EP1048667B1 (de) 2003-10-22
AU761391B2 (en) 2003-06-05
PT1048667E (pt) 2004-03-31
IN192746B (de) 2004-05-15
HK1062678A1 (zh) 2004-11-19
JP3510560B2 (ja) 2004-03-29
DE60006026D1 (de) 2003-11-27
PL339985A1 (en) 2000-11-06
CA2307080C (en) 2003-12-23
BR0002070A (pt) 2000-10-31
HUP0001700A2 (en) 2001-03-28
ZA200002057B (en) 2001-10-26
DK1048667T3 (da) 2004-03-01
PT1380585E (pt) 2005-03-31
ES2232805T3 (es) 2005-06-01
CN1274724A (zh) 2000-11-29
US20010039347A1 (en) 2001-11-08
AR029450A1 (es) 2003-07-02
ES2207464T3 (es) 2004-06-01
DK1380585T3 (da) 2005-03-07
JP2000344771A (ja) 2000-12-12
KR100346619B1 (ko) 2002-07-26
US6326495B2 (en) 2001-12-04
HU0001700D0 (en) 2000-07-28
CN1160353C (zh) 2004-08-04
IL135809A0 (en) 2001-05-20
CA2307080A1 (en) 2000-10-30

Similar Documents

Publication Publication Date Title
ATE339417T1 (de) Biphenyl - sulfonamide als duale angiotensin - endothelin - rezeptor - antagonisten
DE60134094D1 (de) C7-taxanester als antitumormittel
NO20016115D0 (no) Substituerte heterocykelkondenserte gamma-karboliner
PT1224180E (pt) Azois substituidos
DE122007000064I1 (de) Erythropoietinkonjugate
DE19983871T1 (de) Fönvorrichtung
DE10084676T1 (de) Einmallanzettvorrichtung
ATE316978T1 (de) Ent-steroide als selektiv wirksame estrogene
ATE357433T1 (de) 4-pyrimidinyl-n-acyl-l-phenylanine
PT1218009E (pt) Grandulos de quetiapina
ATE297895T1 (de) 4-pyridinyl-n-acyl-l-phenylalanine
PT1218096E (pt) Microcapsulas de libertacao variavel
DE50011908D1 (de) 16-hydroxyestratriene als selektiv wirksame estrogene
PT1163256E (pt) Hemi-hidrato de 16-alfa-bromoepiandrosterona
DE60003072D1 (de) Thiazolidindion-derivate als antidiabetika
PT1235566E (pt) Formulacao injectavel de valnemulina
DE10085008T1 (de) Oberflächenbehandlungsdüse
NO20022927L (no) Substituerte pyrrazoler
DE19983890T1 (de) Ventiltaktgebungsjustiereinrichtung
ATE440824T1 (de) Nitro-sulfobenzamide
NO20020069L (no) Stigerörsystem
ATE282039T1 (de) Pyrazolopyridinon als zwischenprodukt
ATE269311T1 (de) Benzoylpyridazine
DE10082008D2 (de) Ausbeulgerät
DK1200423T3 (da) Substituerede pehnyluraciler

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee